Orforgliprons approval highlights both the growing role of GLP-1 therapies in weight loss and the potential for faster regulatory pathways, bringing new treatments to patients sooner
Medications such as semaglutide and tirzepatide are now revealing their versatility in addressing a diverse range of complex health conditions, offering a beacon of hope for improved chronic disease management and patient outcomes
Which carriers are offering better terms on specialty drug management right now
Food and Drug Administration (FDA) found 185 cases of sexual dysfunction reported among users of GLP-1 receptor agonists
Yang X, Bhowmick K, Rao S, Xiang X, Ohshiro K, Amdur RL, Hassan MI, Mohammad T, Crandall K, Cifani P, Shetty K, Lyons SK, Merrill JR, Vegesna AK, John S, Latham PS, Crawford JM, Mishra B, Dasarathy S, Mishra L
5 Questions to Ask Before You Start If youre in Chelsea, Michigan, and starting to feel less sharp, less energetic, or just not quite like yourself, youre not alone